T1	Participants 228 361	25 normally intelligent high-functioning pervasive developmental disorder (HPDD) patients (mean age, 24.2 years; 24 male, one female)
T2	Participants 366 422	215 controls (mean age, 30.4 years; 86 male, 129 female)
T3	Participants 678 682	HPDD
T4	Participants 701 709	controls
